Animal Models for Swine Influenza: Model Roles, Limits, and Surveillance Implications

A recent review of swine influenza animal models describes how experimental readouts can shift depending on whether studies are conducted in mice, ferrets, guinea pigs, pigs, or non-human primates. The authors organize cross-species similarities and differences across three dimensions—pathological manifestations, viral replication kinetics, and immune architecture. A consistent theme is that the same virus can produce distinct patterns of respiratory injury, viral dynamics, and immunophenotyping opportunities across hosts. These differences are framed as practical determinants of what each model can and cannot represent within SIV research.

Against that backdrop, the review catalogs the main in vivo systems and summarizes their typical experimental roles. Small-animal platforms are described as enabling controlled, scalable studies that support mechanistic dissection and early-stage screening, while transmission-focused systems are useful for studying spread and upper-airway replication in ways not always captured by other models. Natural-host studies are settings in which disease course and immune architecture can be observed together under conditions intended to approximate field infection. The authors also outline a tiered, multi-model strategy that sequences platforms from early exploration to later confirmation, aligning specific hypotheses with model capabilities rather than treating any single host as a universal surrogate.

Qualitative contrasts across models are illustrated by differences in pulmonary lesion distribution, transmission efficiency, and the apparent completeness of respiratory mucosal immune development. The authors describe how some models show prominent inflammatory patterns that do not mirror the lesion topography commonly emphasized for the natural host, while others more readily support respiratory spread without offering the same depth of cellular immune characterization. The review also highlights variation in immune-system complexity across species, noting that the ability to profile diverse cellular subsets and regulatory pathways differs substantially between models and may shape what “protection” looks like depending on the endpoint selected. In aggregate, these biological differences are presented as a key reason findings may not translate uniformly across species, even when experimental intent is similar.

Route of infection and inoculation dose are treated as cross-cutting variables that further influence how comparable results are between studies and hosts. The review contrasts natural transmission routes—such as aerosols, inhaled droplets, and contact exposure—with experimental approaches that use high-dose intranasal or intratracheal inoculation to ensure infection. High-dose direct deposition into the lower respiratory tract can generate non-physiological patterns of pneumonia and may obscure early mucosal events, complicating interpretation when comparing across models. In that context, aerosol nebulization or environmentally simulated contact exposure may better mimic natural infection than high-dose inoculation routes. The discussion closes by emphasizing route and dose as determinants of cross-model relevance and interpretive framing.

The pig model is described as the natural-host platform in which coordinated mucosal and cellular responses can be captured alongside clinically recognizable respiratory disease, allowing immunogenicity and immunopathology to be observed together. In that setting, the review discusses vaccine-associated enhanced respiratory disease (VAERD) as an observation reported in pig studies under antigen-mismatched conditions, where non-neutralizing responses have been linked to worsened pulmonary inflammation and lesion severity. The authors summarize a typical natural-infection timeline in pigs, with clinical signs at about 2–3 days post infection (dpi), peak pulmonary lesions and viral shedding around 5–7 dpi, and viral clearance largely completed by roughly 10–14 dpi. Overall, pig-model readouts and timing are presented as central to the review’s translational and surveillance-oriented interpretation of SIV experiments.

Key Takeaways:

• The review presents a role-aligned, tiered multi-model framework in which different hosts are described as contributing complementary evidence across pathology, kinetics, and immune architecture.
• Reported inter-model divergence—spanning lesion patterns, transmission behavior, mucosal immune development, and cellular immune complexity—is described as a recurring source of limited one-to-one translation across species.
• Pig studies are portrayed as a critical platform for confirming protective efficacy and evaluating potential immunopathological risks (including VAERD) in the natural host.